Strüngmann Brothers invest in eHealth Specialist ICW

InterComponentWare AG (ICW)Santo Holding (Germany) GmbH of Hexal founders Strüngmann secured a 25 percent share in the eHealth specialist InterComponentWare AG (ICW). This transaction was performed by the purchase of newly issued shares in the context of an increase in capital stock. The present owners of ICW do not surrender any shares in this transaction.

ICW will invest its newly acquired funds into the further expansion of its leading position in the international eHealth market. The company is one of the internationally active eHealth pioneers and offers a very broad range of solutions focusing on citizens respectively patients.

ICW pursues two strategic approaches to improve communication and thus also quality and efficiency in the health care system: First of all, it supports the introduction of ubiquitous secure health care IT infrastructures with electronic health cards and personal health records. At the beginning of 2007, ICW was awarded the pilot project for the introduction of the national electronic health card in Bulgaria. The company also conducts a field test for the electronic health card in Germany since 2005, which includes the personal health record LifeSensor. The LifeSensor technology is also applied in the BARMER research project, in which Germany's largest health insurance company will offer its approx. 7 million insurants a personal health record.

ICW's second strategic approach is to network medical professionals in medical practices and hospitals with each other. PPV, for example, a Bavarian physician's network, uses ICW solutions to give its approximately 350 members a comprehensive view of their patients' medical data. Heidelberg University Hospital also opted for a solution developed by ICW to network with its partner hospitals. This solution also incorporates patients and resident physicians into the improved data flow.

"The trust of our new investors in ICW shows that we are pursuing the right strategy and that our solutions have a large national and international market potential", explains ICW's CEO Peter Reuschel. The Strüngmann brothers are also absolutely convinced that ICW will continue to expand its position in the global eHealth market: "We opted for an investment in ICW, because it is in a perfect position to assert itself in the high-growth global eHealth market with its open platform approach and mature solutions. With its networking solutions, ICW has the potential to make the national and global health care market more efficient. We want to support and accompany this process", explain the Strüngmann brothers.

Related news articles:

About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, the United States, Austria, Switzerland and Bulgaria. Its solutions for networking the various players in the healthcare system lastingly improve process-oriented communication and data integrity, and therefore also the quality of healthcare. Among other things, ICW develops and distributes software and hardware components for the healthcare IT infrastructure for electronic health cards, the LifeSensor personal health record as well as networking solutions for hospitals and physician offices. As part of the bIT4health consortium, ICW provided important consulting services for the implementation of the electronic health card in Germany, is involved in the Austrian eCard project and has won the pilot project for the national health card in Bulgaria. For further information, visit:

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...